Source: Richard Craver, WINSTON-SALEM JOURNAL, 2/18/20



A biopharmaceutical company owned by Reynolds American Inc. is attempting again to determine whether tobacco plants can play a role in battling coronavirus. Kentucky BioProcessing LLC is infecting fast-growing tobacco plants with a genetically modified coronavirus to see if it can produce antibodies for a possible vaccine, according to Politico. Reynolds bought certain assets and liabilities of Kentucky BioProcessing in January 2014...

For more of this story, click here.